• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者大脑中钙依赖和非钙依赖的蛋白激酶C变化。

Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.

作者信息

Matsushima H, Shimohama S, Chachin M, Taniguchi T, Kimura J

机构信息

Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto, Japan.

出版信息

J Neurochem. 1996 Jul;67(1):317-23. doi: 10.1046/j.1471-4159.1996.67010317.x.

DOI:10.1046/j.1471-4159.1996.67010317.x
PMID:8667008
Abstract

We examined protein kinase C (PKC) activity in Ca2+-dependent PKC (Ca2+-dependent PKC activities) and Ca2+-independent PKC (Ca2+-independent PKC activities) assay conditions in brains from Alzheimer's disease (AD) patients and age-matched controls. In cytosolic and membranous fractions, Ca2+-dependent and Ca2+-independent PKC activities were significantly lower in AD brain than in control brain. In particular, reduction of Ca2+-independent PKC activity in the membranous fraction of AD brain was most enhanced when cardiolipin, the optimal stimulator of PKC-epsilon, was used in the assay; whereas Ca2+-independent PKC activity stimulated by phosphatidylinositol, the optimal stimulator of PKC-delta, was not significantly reduced in AD. Further studies on the protein levels of Ca2+-independent PKC-delta, PKC-epsilon and PKC-zeta in AD brain revealed reduction of the PKC-epsilon level in both cytosolic and membranous fractions, although PKC-delta and PKC-zeta levels were not changed. These findings indicated that Ca2+-dependent and Ca2+-independent PKC are changed in AD, and that among Ca2+-independent PKC isozymes, the alteration of PKC-epsilon is a specific event in AD brain, suggesting its crucial role in AD pathophysiology.

摘要

我们在阿尔茨海默病(AD)患者及年龄匹配的对照者大脑中,于钙离子依赖型蛋白激酶C(Ca2+依赖型PKC活性)和钙离子非依赖型蛋白激酶C(Ca2+非依赖型PKC活性)的检测条件下,检测了蛋白激酶C(PKC)活性。在胞质和膜组分中,AD大脑中Ca2+依赖型和Ca2+非依赖型PKC活性均显著低于对照大脑。特别是,当使用心磷脂(PKC-ε的最佳刺激物)进行检测时,AD大脑膜组分中Ca2+非依赖型PKC活性的降低最为明显;而由磷脂酰肌醇(PKC-δ的最佳刺激物)刺激的Ca2+非依赖型PKC活性在AD中未显著降低。对AD大脑中Ca2+非依赖型PKC-δ、PKC-ε和PKC-ζ蛋白水平的进一步研究显示,尽管PKC-δ和PKC-ζ水平未改变,但胞质和膜组分中PKC-ε水平均降低。这些发现表明,AD中Ca2+依赖型和Ca2+非依赖型PKC均发生了变化,并且在Ca2+非依赖型PKC同工酶中,PKC-ε的改变是AD大脑中的一个特定事件,提示其在AD病理生理学中起关键作用。

相似文献

1
Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease.阿尔茨海默病患者大脑中钙依赖和非钙依赖的蛋白激酶C变化。
J Neurochem. 1996 Jul;67(1):317-23. doi: 10.1046/j.1471-4159.1996.67010317.x.
2
Attenuated protein kinase C activity and translocation in Alzheimer's disease brain.阿尔茨海默病大脑中蛋白激酶C活性减弱及易位
Neurobiol Aging. 1994 May-Jun;15(3):293-8. doi: 10.1016/0197-4580(94)90023-x.
3
Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease.通过双位点酶免疫测定法评估人脑中的蛋白激酶C同工酶以及阿尔茨海默病中的变化。
Neurology. 1993 Jul;43(7):1407-13. doi: 10.1212/wnl.43.7.1407.
4
Expression and activity of protein kinase C isoenzymes during normal and abnormal murine palate development.正常和异常小鼠腭部发育过程中蛋白激酶C同工酶的表达与活性
J Craniofac Genet Dev Biol. 2000 Jan-Mar;20(1):26-34.
5
Selective subcellular redistributions of protein kinase C isoforms by chemical hypoxia.化学性缺氧导致蛋白激酶C亚型的选择性亚细胞重新分布。
J Neurosci Res. 1999 Jun 15;56(6):668-78. doi: 10.1002/(SICI)1097-4547(19990615)56:6<668::AID-JNR13>3.0.CO;2-R.
6
Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.正常和阿尔茨海默病大脑中枢神经系统中三种主要人类蛋白激酶C同工酶(PKCα、PKCβ和PKCγ)的特性及差异分布
Lab Invest. 1991 Jan;64(1):35-44.
7
Protein kinase C activity and protein levels in Alzheimer's disease.阿尔茨海默病中的蛋白激酶C活性与蛋白水平
Brain Res. 1997 Aug 1;764(1-2):75-80. doi: 10.1016/s0006-8993(97)00422-8.
8
Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells.RAW 264.7细胞呼吸爆发和吞噬作用中经典和新型蛋白激酶C亚型的差异需求
J Immunol. 2000 Sep 1;165(5):2809-17. doi: 10.4049/jimmunol.165.5.2809.
9
Differential involvement of protein kinase C isozymes in Alzheimer's disease.蛋白激酶C同工酶在阿尔茨海默病中的不同参与情况。
J Neurosci. 1990 Jul;10(7):2113-24. doi: 10.1523/JNEUROSCI.10-07-02113.1990.
10
Protein kinase C-zeta activity but not level is decreased in Alzheimer's disease microvessels.蛋白激酶C-ζ的活性而非水平在阿尔茨海默病微血管中降低。
Neurosci Lett. 1998 Sep 18;254(1):29-32. doi: 10.1016/s0304-3940(98)00653-3.

引用本文的文献

1
Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer's Disease.轻度认知障碍患者脑脊液中生长相关蛋白43(GAP-43)升高,通过淀粉样β蛋白(Aβ)积累增加与认知障碍相关,而在阿尔茨海默病中则转变为Aβ积累减少。
J Mol Neurosci. 2025 Mar 20;75(2):39. doi: 10.1007/s12031-025-02333-8.
2
Expression of ITPR2 regulated by lncRNA-NONMMUT020270.2 in LPS-stimulated HT22 cells.lncRNA-NONMMUT020270.2调控的ITPR2在脂多糖刺激的HT22细胞中的表达
Heliyon. 2024 Jun 25;10(13):e33491. doi: 10.1016/j.heliyon.2024.e33491. eCollection 2024 Jul 15.
3
Marine-derived Compounds: A Powerful Platform for the Treatment of Alzheimer's Disease.
海洋来源化合物:治疗阿尔茨海默病的有力平台。
Cent Nerv Syst Agents Med Chem. 2024;24(2):166-181. doi: 10.2174/0118715249269050231129103002.
4
Bryostatin-1: a promising compound for neurological disorders.苔藓抑素-1:一种治疗神经疾病的有前景的化合物。
Front Pharmacol. 2023 Jun 7;14:1187411. doi: 10.3389/fphar.2023.1187411. eCollection 2023.
5
Calcium Homeostasis, Transporters, and Blockers in Health and Diseases of the Cardiovascular System.钙稳态、转运体和阻滞剂在心血管系统的健康和疾病中的作用。
Int J Mol Sci. 2023 May 15;24(10):8803. doi: 10.3390/ijms24108803.
6
GAP-43 and BASP1 in Axon Regeneration: Implications for the Treatment of Neurodegenerative Diseases.生长相关蛋白43和脑酸性可溶性蛋白1在轴突再生中的作用:对神经退行性疾病治疗的启示
Front Cell Dev Biol. 2020 Sep 3;8:567537. doi: 10.3389/fcell.2020.567537. eCollection 2020.
7
Protein Kinase Cɛ in the Platelet and Hippocampal Tissue as a Diagnostic Biological Marker in Alzheimer Disease.血小板和海马组织中的蛋白激酶Cɛ作为阿尔茨海默病的诊断生物标志物
Basic Clin Neurosci. 2019 Nov-Dec;10(6):545-556. doi: 10.32598/bcn.9.10.80.1. Epub 2019 Nov 1.
8
The Transcriptional Regulatory Properties of Amyloid Beta 1-42 may Include Regulation of Genes Related to Neurodegeneration.淀粉样蛋白β 1-42 的转录调控特性可能包括对与神经退行性变相关基因的调控。
Neuromolecular Med. 2018 Sep;20(3):363-375. doi: 10.1007/s12017-018-8498-6. Epub 2018 Jun 12.
9
Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes.抑制蛋白激酶 Cδ可降低淀粉样蛋白-β水平并逆转阿尔茨海默病表型。
J Exp Med. 2018 Jun 4;215(6):1665-1677. doi: 10.1084/jem.20171193. Epub 2018 May 8.
10
ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation.载脂蛋白E4和β-淀粉样蛋白寡聚体通过组蛋白去乙酰化酶核转位降低脑源性神经营养因子的表达。
J Neurosci. 2015 May 13;35(19):7538-51. doi: 10.1523/JNEUROSCI.0260-15.2015.